Help
RSS
API
Feed
Maltego
Contact
Domain > www.navidea.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-10-22
184.73.186.24
(
ClassC
)
2025-05-06
13.57.74.156
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Tue, 06 May 2025 17:51:37 GMTServer: ApacheExpires: Thu, 19 Nov 1981 08:52:00 GMTCache-Control: no-store, no-cache, must-revalidate, post-check0, pre-check0Pragma: no-cacheVary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE html>!--if lt IE 7> html classno-js lt-ie9 lt-ie8 lt-ie7 langen> !endif-->!--if IE 7> html classno-js lt-ie9 lt-ie8 langen> !endif-->!--if IE 8> html classno-js lt-ie9 lt-ie10 langen> !endif-->!--if IE 8> html classno-js lt-ie10 langen> !endif-->!--if gt IE 9>!--> html classno-js langen> !--!endif--> head> meta charsetutf-8> title>Navidea Biopharmaceuticals, Inc. (NAVB)/title> meta namedescription contentNavidea Biopharmaceuticals, Inc. is a leader in precision medicine with immuno-targeted products.> meta propertyog:site_name contentNavidea Biopharmaceuticals, Inc.> meta propertyog:title contentNavidea Biopharmaceuticals, Inc. (NAVB)> meta propertyog:type contentwebsite> meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/logo.png> meta propertyog:url contenthttps://www.navidea.com> meta propertyog:description contentNavidea Biopharmaceuticals, Inc. is a leader in precision medicine with immuno-targeted products.> meta nameviewport contentinitial-scale1.0, widthdevice-width> link hrefhttps://fonts.googleapis.com/css?familyRoboto:300,400,400italic,500,700 relstylesheet> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/css/style.css> link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/favicon.ico> link relapple-touch-icon sizes180x180 hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/apple-touch-icon.png> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/favicon-32x32.png sizes32x32> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/favicon-16x16.png sizes16x16> link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/manifest.json> link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/favicons/safari-pinned-tab.svg> meta nametheme-color content#ffffff> script> (function(i,s,o,g,r,a,m){iGoogleAnalyticsObjectr;irir||function(){ (ir.qir.q||).push(arguments)},ir.l1*new Date();as.createElement(o), ms.getElementsByTagName(o)0;a.async1;a.srcg;m.parentNode.insertBefore(a,m) })(window,document,script,https://www.google-analytics.com/analytics.js,ga); ga(create, UA-99304366-1, navidea.com); (function() { var opts {}; var prefix /investors; if (location.hostname.indexOf(dev-ir.stockpr.com) 0) { opts.cookiePath location.pathname.substring(0, location.pathname.indexOf(/, 1) + 1) opts.page prefix + location.pathname.substring(location.pathname.indexOf(/, 1)); } else if (location.hostname.match(/^ir\./)) { opts.page prefix + location.pathname; } ga(send, pageview, opts); })(); /** * Function that tracks a click on an outbound link in Analytics. * This function takes a valid URL string as an argument, and uses that URL string * as the event label. Setting the transport method to beacon lets the hit be sent * using navigator.sendBeacon in browser that support it. */ var trackOutboundLink function(url,category) { if (!category) category outbound; ga(send, event, category, click, url, { transport: beacon }); } window.onload function() { // Add outbound link tracking in GA jq(a).not(.fancybox).each(function(){ var href jq(this).attr(href); if (typeof href undefined) return; if (href.indexOf(http) > 0 && ( href.indexOf(website_base_url) 0 && href.indexOf(ir_base_url) 0 && href.indexOf(eqcdn) 0 && href.indexOf(amazonaws) 0)) { jq(this).attr(onclick, trackOutboundLink( + href + )); }else { // Its not an outbound link, but if its a link to a file, we want to track that. if (href.match(/(\.pdf|\.jpg|\.png|\.gif|\.ppt|\.jpeg|\.mp3|\.mp4|\.wav|\.docx|\.doc|\.xsl|\.cslx)/g)) { jq(this).attr(onclick, trackOutboundLink( + href + , documents-and-files)); } } }); };/script> /head>body classpg-1 page-type-default pg-overview-overview home> div classgeneral-wrapper> header classaffixed> div classcontainer> h1 classlogo> a href/> img classlogo srchttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/logo-white.png width200 height60 altNavidea Biopharmaceuticals, Inc.> img classsticky-logo srchttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/images/logo-color.png width168 height44 altNavidea Biopharmaceuticals, Inc. /> /a> /h1> a classvisible-xs visible-sm mobile-nav-trigger idshowRight> div classmeat>/div> div classmeat>/div> div classmeat>/div> /a> nav classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav> ul classmain-menu> li classsr-only>a href/>Home/a>/li> li classhas-children data-submenu-idsubmenu-about> a href/about>About/a> ul idsubmenu-about> li class >a href/about>Overview/a>/li> li class >a href/about/management-team>Management Team/a>/li> li class >a href/about/board-of-directors>Board of Directors/a>/li> li class >a href/about/careers>Careers/a>/li> /ul> /li> li classhas-children data-submenu-idsubmenu-technology> a href/technology>Technology/a> ul idsubmenu-technology> li class >a href/technology>Overview/a>/li> li class >a href/technology/grant-funding>Grant Funding/a>/li> /ul> /li> li class data-submenu-idsubmenu-pipeline> a href/pipeline>Pipeline/a> /li> li classhas-children data-submenu-idsubmenu-news-media> a href/news-media>News & Media/a> ul idsubmenu-news-media> li class >a href/news-media/press-releases>Press Releases/a>/li> li class >a href/news-media/events>Events/a>/li> li class >a href/news-media/publications>Publications/a>/li> li class >a href/news-media/in-the-news>In the News/a>/li> /ul> /li> li classhas-children data-submenu-idsubmenu-investors> a href/investors>Investors/a> ul idsubmenu-investors> li class >a href/investors/_>Overview/a>/li> li classhas-children >a href/investors/news-events>News / Events/a>/li> li classhas-children >a href/investors/company-information>Company Information/a>/li> li classhas-children >a href/investors/financial-information>Financial Information/a>/li> li classhas-children >a href/investors/stock-data>Stock Data/a>/li> li classhas-children >a href/investors/sec-filings>SEC Filings/a>/li> li classhas-children >a href/investors/corporate-governance>Corporate Governance/a>/li> /ul> /li> li class data-submenu-idsubmenu-contact> a href/contact>Contact/a> /li> /ul> /nav> /div>/header>div classpage-banner overlay dark home-hero stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/db/306/1719/image_home.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;> div classcontainer> div classrow> div classcol-lg-10 col-lg-offset-1> div classtext center> h2>Navidea Envisions a World Where Disease can be Precisely Identified and Treated/h2> p>p>Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care./p>p> Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. /p>/p> a href/about classbtn>Learn More/a> /div> /div> /div> /div>/div>div classmodule center> div classcontainer> div classrow js-same-height-row> div classcol-sm-8 col-sm-offset-2> div classmodule-content> div classvertical-align js-height js-same-height> div classwrapper> h3>/h3> h2>Third-Party Asset Valuation of Tc99m Tilmanocept for Indications in Rheumatoid Arthritis/h2>a hrefhttps://d1io3yog0oux5.cloudfront.net/navidea/files/pages/navidea/db/335/description/Navidea_Biopharmaceuticals_RA_U.S._and_EU_Valuation_Apr22_.pdf classbtn target_blank onclicktrackOutboundLink("https://d1io3yog0oux5.cloudfront.net/navidea/files/pages/navidea/db/335/description/Navidea_Biopharmaceuticals_RA_U.S._and_EU_Valuation_Apr22_.pdf") relnoopener>DOWNLOAD REPORT/a> br> /div> /div> /div> /div> /div> /div>/div>div classhome-news-module> div classcontainer-fluid> div classrow js-same-height-row> div classcol-sm-6> section classjs-same-height> h3>Latest News/h3> div classdate>Mar 31, 2025/div>h2>a hrefhttps://www.navidea.com/news-media/press-releases/detail/453/navidea-biopharmaceuticals-announces-the-extension-of-plan>Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets/a>/h2> /section> a hrefhttps://www.navidea.com/news-media/press-releases classbtn>View All News/a> /div> div classcol-sm-5 col-sm-offset-1> section classjs-same-height> h3>Latest Event/h3> div classdate>Jul 8, 2024 • 1:00pm EDT/div> h2>Special Meeting of Stockholders/h2> /section> a hrefhttps://ir.navidea.com/ir-calendar classbtn>View All Events/a> /div> /div> /div>/div>div classstock-info quote-box data-symbolNAVB> div classhome-ir-module> div classtitle-header center> h2>Navidea Biopharmaceuticals, Inc./h2> span classdate>time datetime2025>/time>/span> /div> div classcontainer> div classrow> div classcol-md-12> div classtext> div classrow js-same-height-row> div class col-md-4 col-sm-12 col-xs-12 symbol stock-section> div classstock-box js-same-height> h3 classvalue-title>Symbol/h3> span classvalue>NYSE American: NAVB/span> /div> /div> div classcol-md-4 col-sm-12 col-xs-12 price stock-section> div classstock-box price js-same-height> h3 classvalue-title>Price/h3> span classvalue>span classloader>/span>/span> /div> /div> div classcol-md-4 col-sm-12 col-xs-12 change stock-section> div classstock-box change js-same-height> h3 classvalue-title>Change/h3> span>span classeqicon-change-02>/span> span classvalue>span classnumber>span classloader>/span>/span> span classpercent>/span>/span>/span> /div> /div> /div> div classrow home-stock-row-bottom> div classcol-md-4 col-sm-12 col-xs-12 stock-section> div classstock-box volume> h3 classvalue-title>Volume/h3> span classvalue>span classloader>/span>/span> /div> /div> div classcol-md-4 col-sm-12 col-xs-12 stock-section> div classstock-box day-range> h3 classvalue-title>Day Range/h3> span classvalue>span classloader>/span>/span> /div> !-- .stock-box --> /div> !-- .stock-section --> div classcol-md-4 col-sm-12 col-xs-12 stock-section> div classstock-box week-range> h3 classvalue-title>Year Range/h3> span classvalue>span classloader>/span>/span> /div> !-- .stock-box --> /div> !-- .stock-section --> /div> /div> /div> /div> /div> div classhome-links-module> div classcontainer> a classbtn hrefhttps://ir.navidea.com>View Investor Relations/a> a classbtn hrefhttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/db/299/2395/pdf/NAVB+Investor+Public+May+2022.pdf target_blank>View Investor Presentation/a> /div> /div> /div>/div>footer> div classcontainer> div classcopyright> © 2025 a href/>Navidea Biopharmaceuticals, Inc./a> All Rights Reserved. /div> div classfooter-social> a relnofollow hrefhttp://linkedin.com/company/navidea-bio target_blank>span classicon eqicon-social-01-linkedin>/span> span classsr-only>linkedin/span>/a> /div> div classfooter-links> a href/privacy-policy>Privacy Policy/a> a href/disclaimer>Disclaimer/a> a href/sitemap>Sitemap/a> /div> /div>/footer>script> var asset_url https://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea; var website_base_url https://www.navidea.com; var ir_base_url https://ir.navidea.com; var hCaptchaSiteKey 778a5748-d323-4b73-a06c-9625642de8bc;/script>script srchttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/js/_js/all.js>/script>script typetext/javascript> jq.ajax({ url: https://www.navidea.com/api/v1/quote, dataType: jsonp, jsonpCallback: populateQuoteBox, crossDomain: true }).done(function(response) { // Do nothing. }).fail(function(error) { console.log(ERROR retrieving quote: + error.statusText); });/script>script srchttps://d1io3yog0oux5.cloudfront.net/_5f3acbfcea77b28010e27c0a7021da30/navidea/files/theme/js/aside/_js/browser-check.min.js async>/script> /div>!-- //general-wrapper -->/body>
Subdomains
Date
Domain
IP
ir.navidea.com
2024-06-14
52.9.170.196
www.navidea.com
2025-05-06
13.57.74.156
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]